Table 3 Multivariate analysis
From: The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
Prognostic factor | Hazard ratio | 95% confidence interval | P -value |
---|---|---|---|
(A) Including lymphadenectomy | |||
Year of diagnosisa | 0.98 | 0.96–0.99 | 0.004 |
Age at diagnosisa | 1.03 | 1.02–1.03 | <0.001 |
Surgeryb | 0.17 | 0.15–0.20 | <0.001 |
Stagec | 2.45 | 2.19–2.75 | <0.001 |
Histologyd | 1.30 | 1.20–1.42 | <0.001 |
Gradee | 1.57 | 1.42–1.73 | <0.001 |
(B) Excluding lymphadenectomy | |||
Year of diagnosisa | 0.99 | 0.97–1.00 | 0.098 |
Age at diagnosisa | 1.03 | 1.02–1.03 | <0.001 |
Surgeryb | 0.19 | 0.16–0.23 | <0.001 |
Lymphadenectomyb | 0.68 | 0.59–0.78 | <0.001 |
Stagec | 2.48 | 2.22–2.78 | <0.001 |
Histologyd | 1.28 | 1.17–1.39 | <0.001 |
Gradee | 1.56 | 1.43–1.73 | <0.001 |